<?xml version="1.0" encoding="UTF-8"?>
<ref id="B110">
 <label>110.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Gabay</surname>
    <given-names>C</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Emery</surname>
    <given-names>P</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Van Vollenhoven</surname>
    <given-names>R</given-names>
   </name>
  </person-group>
  <etal/>
  <article-title>Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial</article-title>. 
  <source>Lancet</source>
  <volume>381</volume>(
  <issue>9877</issue>), 
  <fpage>1541</fpage>â€“
  <lpage>1550</lpage> (
  <year>2013</year>).
  <pub-id pub-id-type="pmid">23515142</pub-id>
 </mixed-citation>
</ref>
